The leading French pharmaceutical company Sanofi is to establish a Center of Excellence in Budapest, the Hungarian Investment Promotion Agency (HIPA) announced. Initially, a hundred people will assist Sanofi subsidiaries in the field of accounting, HR and finance in seven languages, however, the center will be expanded to 350 persons by 2022.
Sanofi was founded in 1973 and its products are distributed in 170 countries worldwide. The company group is headquartered in Paris and employs over 100,000 people in 100 countries.
"Being one of the top pharmaceutical companies in Hungary, the 16th largest exporter of our national economy and the 21st company in terms of revenue, Sanofi has been the strategic partner of the Hungarian government since 2013. Chemical development and production takes place at the location of Budapest, as well as the R&D center, but they also have smaller manufacturing units in Veresegyháza and Csanyikvölgy, near Miskolc," a HIPA says. The company's logistics and distribution site in Nagytétény in SW Budapest supplies more than 50 customers from the products of 59 factories with some 290 million boxes of medication on a yearly basis.
With its latest investment, Sanofi joins the more than 110 service centers that operate in Hungary; these employ over 50,000 people, typically the members of generation Y, with a higher education degree and speaking foreign language skills. Sanofi considers the new unit not as a simple business services center (BSC), but a Center of Excellence, which will perform tasks with specifically high added value. The new office will initially assist Sanofi's European and North-American subsidiaries, however, with the planned dynamic headcount increase the service portfolio is also anticipated to expand.


Leave a Reply Cancel reply
Top 5 Articles
Hungarian Inflation Rate - the Highest in Europe December 16, 2022
In Strategic Partnership with the Client January 2, 2023
Customer Focus Above All January 6, 2023
Future FM, the Solution Provider January 4, 2023
ASTRASUN Solar and Partners Sign Cooperation Agreement January 24, 2023
No comment yet. Be the first!